FDA Approved: RIFABUTIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rifabutin from Mylan Pharmaceuticals Inc., updating labeling and approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection
• Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

SUPPL AP for RIFABUTIN (RIFABUTIN)